Treatment targeting immune-regulating neutrophil activation may reduce pathological thrombosis in COVID-19 patients, researchers report.
Click here for original story, Changes in the blood, not the heart, may underlie cardiac thrombosis in COVID-19 patients
Source: ScienceDaily